Rene Russo is President at Xilio Therapeutics, Inc. (XLO). They have made 1 open-market trade across 1 company since 2025, most recently 2026-01-01.
CIK 0001722066
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XLO | 325,422 | $2.9M |
Shares reported on the most recent Form 4, priced at the 2026-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLO | BUY | 2025-06-16 | 2025-06-18 | $0.68 | $25K | -1.0% | +3.2% | +9.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.